Plasma biomarker screening could improve accuracy, health equity in Alzheimer’s disease diagnosis
A new study focuses on RNA molecules in plasma as biomarkers for Alzheimer’s disease in African Americans — the population at greatest risk for developing Alzheimer’s disease. This approach enabled researchers to pinpoint specific molecules in plasma that could serve as biomarkers to confirm a diagnosis of Alzheimer’s disease in this population.
Read Original Article: Plasma biomarker screening could improve accuracy, health equity in Alzheimer’s disease diagnosis »
